ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015: Radiant Insights, Inc. This report presents the findings from a survey of 113 pharmaceutical companies regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting. Key Findings Kable’s survey of 113 pharmaceutical companies highlights that X% of respondents anticipate an increase in their ICT budgets in 2014, which is an increase of X% compared to 2013. According to Kable’s survey, pharmaceutical companies are planning to invest X% of their external ICT budgets in hardware, software, and IT services in 2014, which is more than the combined allocation in 2013 (X%). View Full Reports with Toc @ http://www.radiantinsights.com/research/ict-investment-trendsin-pharmaceuticals-enterprise-ict-spending-patterns-through-to-the-end Pharmaceutical companies are allocating the highest proportion of their software budgets to application lifecycle management (X%) followed by enterprise applications (X%) and information management (X%) in 2013. Synopsis This report presents the findings from a survey of 113 pharmaceutical companies regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting. The report illustrates the core technologies enterprises are investing in, including business intelligence, content management, and cloud computing. The survey also highlights the approach adopted by the pharmaceutical companies to purchase technology. Through Kable’s survey, the report aims to provide better insight to ICT vendors and services providers when pitching their solutions to pharmaceutical companies.
In particular, it provides an in-depth analysis of the following: Understand how ICT budgets are set to change in 2014 in terms of their overall size.
Appreciate how IT budgets are allocated across the core elements of IT spend, including hardware, software, services, communications, and consulting. Learn how IT money is being spent in areas such as the data centre, applications, IT management and the network. Gain an understanding regarding which ICT functions pharmaceutical companies are interested in outsourcing. Identify pharmaceutical companies’ investment priorities based on their budget allocations across core technology categories such as business intelligence, content management and cloud computing. Learn about the drivers that are influencing pharmaceutical companies’ investments in each technology category. Establish how pharmaceutical companies IT budgets are currently allocated across various segments within a technology category. View Full Reports with Toc @ http://www.radiantinsights.com/research/ict-investment-trendsin-pharmaceuticals-enterprise-ict-spending-patterns-through-to-the-end Gain insight into how pharmaceutical companies plan to change their ICT budget allocations across various segments within a technology category. Understand the vendor mindshare for various core and advanced technology categories. Provides insight into pharmaceutical companies’ preferred buying approaches. Comprehend the business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies. Understand the factors that are influencing pharmaceutical companies’ decision to select an ICT provider.
Reasons To Buy This report will help readers to understand how the pharmaceutical companies ICT landscape is set to change in 2014. Gain a view as to how ICT money is being allocated in your target audience.
The report covers a detailed breakdown of the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications and consulting.) The report will help users to gain a view of the current strategic objectives of pharmaceutical companies. The report will provide a detailed breakdown of the opportunities within selected technology categories (business intelligence, content management, and cloud computing). Understand the factors that are influencing pharmaceutical companies’ decision to select an ICT provider. Gain a view as to the business and IT objectives pharmaceutical companies are looking to achieve through their ICT investment strategies. View Full Reports with Toc @ http://www.radiantinsights.com/research/ict-investment-trendsin-pharmaceuticals-enterprise-ict-spending-patterns-through-to-the-end Table of Contents 1 Trends in ICT budgets 1.1 Introduction 1.2 Survey demographics 1.3 ICT budget changes 1.4 ICT budget allocation by core technology area 1.4.1 Hardware budget breakdown 1.4.2 Software budget breakdowns 1.4.3 Third party IT services expenditure 1.4.4 Telecommunications budget 1.5 ICT budget allocation by function 1.6 Outsourced IT functions 2 ICT investment priorities and vendor mindshare 2.1 Introduction 2.1.1 Business intelligence 2.1.2 Content management 2.1.3 Cloud computing 3 ICT procurement trends 3.1 Introduction 3.2 Business objectives influencing IT investment strategy 3.3 IT objectives influencing IT investment strategy 3.4 ICT provider selection
4 Sector-specific trends 4.1 Introduction 4.2 IT spending plans for specific business areas 4.3 Business areas receiving the largest investments 4.4 Business challenges 5 Summary 5.1 Pharmaceuticals are increasingly focusing on IT to remain competitive in the market 6 Appendix 6.1 Definitions 6.2 Further reading 6.3 Contact the authors View Full Reports with Toc @ http://www.radiantinsights.com/research/ict-investment-trendsin-pharmaceuticals-enterprise-ict-spending-patterns-through-to-the-end List of Figures Table 1: Pharmaceuticals - enterprise ICT survey geographic breakdown Table 2: Pharmaceuticals - enterprise ICT survey breakdown by size band (number of employees) Table 3: Recent and expected ICT budget changes among pharmaceutical companies Table 4: Pharmaceutical companies’ (external) ICT budget allocation, 2013 and 2014 Table 5: Pharmaceutical companies’ average hardware budget allocation Table 6: Pharmaceutical companies’ average software budget allocation by technology Table 7: Pharmaceutical companies’ average IT services budget allocation Table 8: Pharmaceutical companies’ average IT consulting services budget allocation Table 9: Pharmaceutical companies’ average telecommunications budget allocation Table 10: Pharmaceutical companies’ ICT budget allocation by function, 2013 and 2014 Table 11: Outsourced IT functions - Pharmaceutical companies’ current and future outsourcing priorities.. Table 12: Business intelligence – pharmaceutical companies’ current and future investment priorities Table 13: Business intelligence – vendor mindshare among pharmaceutical companies Table 14: Content management – pharmaceutical companies’ current and future investment priorities Table 15: Content management – vendor mindshare among pharmaceutical companies Table 16: Cloud computing – pharmaceutical companies’ current and future investment priorities Table 17: Cloud computing – vendor mindshare among pharmaceutical companies Table 18: Business objectives which influence pharmaceuticals’ IT investment strategy Table 19: IT objectives which influence pharmaceuticals’ IT investment strategy Table 20: Factors influencing pharmaceuticals’ decision to choose an ICT provider
Table 21: IT spending plans in 2014 compared to 2013, for specific business areas within pharmaceutical companies Table 22: Top three IT projects in 2014 for pharmaceutical companies Table 23: Importance of the following business challenges for pharmaceutical companies Figure 1: Pharmaceuticals - enterprise ICT survey geographic breakdown Figure 2: Pharmaceuticals - enterprise ICT survey breakdown by size band (number of employees) Figure 3: Recent and expected ICT budget changes among pharmaceutical companies Figure 4: Pharmaceutical companies’ (external) ICT budget allocation, 2013 and 2014 Figure 5: Pharmaceutical companies’ average hardware budget allocation Figure 6: Pharmaceutical companies’ average software budget allocation by technology Figure 7: Pharmaceutical companies’ average IT services budget allocation Figure 8: Pharmaceutical companies’ average IT consulting services budget allocation Figure 9: Pharmaceutical companies’ average telecommunications budget allocation Figure 10: Pharmaceutical companies’ ICT budget allocation by function, 2013 and 2014 Figure 11: Outsourced IT functions - Pharmaceutical companies’ current and future outsourcing priorities. Figure 12: Business intelligence – pharmaceutical companies’ current and future investment priorities View Full Reports with Toc @ http://www.radiantinsights.com/research/ict-investment-trendsin-pharmaceuticals-enterprise-ict-spending-patterns-through-to-the-end Figure 13: Business intelligence – vendor mindshare among pharmaceutical companies Figure 14: Content management – pharmaceutical companies’ current and future investment priorities Figure 15: Content management – vendor mindshare among pharmaceutical companies Figure 16: Cloud computing – pharmaceutical companies’ current and future investment priorities Figure 17: Cloud computing – vendor mindshare among pharmaceutical companies Figure 18: Business objectives which influence pharmaceuticals’ IT investment strategy Figure 19: IT objectives which influence pharmaceuticals’ IT investment strategy Figure 20: Factors influencing pharmaceuticals’ decision to choose an ICT provider Figure 21: IT spending plans in 2014 compared to 2013, for specific business areas within pharmaceutical companies Figure 22: Top three IT projects in 2014 for pharmaceutical companies Figure 23: Importance of the following business challenges for pharmaceutical companies
About Radiant Insights Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. For more information, visit http://www.radiantinsights.com/ Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com